Miller Joseph M's Form 4 filing
Aurinia Pharmaceuticals Inc. (AUPH) · filed Mar 6, 2023
- Accession no.
- 0001628280-23-006531
- Filed
- Mar 6, 2023
- Trade date
- Mar 2, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $101.0K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001600620-24-000014 (Feb 22, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller Joseph MCIK 0001746372 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Stock | AGrant or awardAcquired | +229,421 | –F2 | – | 342,510 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −11,296 | $8.94 | −$100,986.24 | 331,214 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 1 transaction in Table I.